EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Fulvic Acid Attenuates Atopic Dermatitis by Downregulating CCL17/22

Chenxi Wu iD, Anqi Lyu iD, Shijun Shan

Molecules · 2023

DOI: 10.3390/molecules28083507 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecules, 2023. Verfasst von Chenxi Wu und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Xiang'an Hospital of Xiamen University, School of Medicine, Xiamen University, Xiamen 361000, China. Hauptthemen laut MEDLINE: Dermatitis, Atopic. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The main pathogenic factor in atopic dermatitis (AD) is Th2 inflammation, and levels of serum CCL17 and CCL22 are related to severity in AD patients. Fulvic acid (FA) is a kind of natural humic acid with anti-inflammatory, antibacterial, and immunomodulatory effects. Our experiments demonstrated the therapeutic effect of FA on AD mice and revealed some potential mechanisms. FA was shown to reduce TARC/CCL17 and MDC/CCL22 expression in HaCaT cells stimulated by TNF-α and IFN-γ. The inhibitors showed that FA inhibits CCL17 and CCL22 production by deactivating the p38 MAPK and JNK pathways. After 2,4-dinitrochlorobenzene (DNCB) induction in mice with atopic dermatitis, FA effectively reduced the symptoms and serum levels of CCL17 and CCL22. In conclusion, topical FA attenuated AD via downregulation of CCL17 and CCL22, via inhibition of P38 MAPK and JNK phosphorylation, and FA is a potential therapeutic agent for AD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Dermatitis, AtopicAnimalsMiceKeratinocytesNF-kappa BChemokine CCL22p38 Mitogen-Activated Protein KinasesDinitrochlorobenzeneTumor Necrosis Factor-alphaChemokine CCL17Benzopyrans

Stichwörter der Autor:innen

CCL17CCL22atopic dermatitis (AD)fulvic acid (FA)

Substanzen

NF-kappa BChemokine CCL22p38 Mitogen-Activated Protein KinasesDinitrochlorobenzeneTumor Necrosis Factor-alphaChemokine CCL17fulvic acidBenzopyransCcl17 protein, mouse

Autor:innen und Institutionen

  • Department of Dermatology, Xiang'an Hospital of Xiamen University, School of Medicine, Xiamen University, Xiamen 361000, China.
  • Hangzhou Third People's Hospital, Affiliated Hangzhou Dermatology Hospital, Zhejiang University School of Medicine, Hangzhou 310009, China.
  • Chen Hongduo Academician Workstation, Shaoxing Central Hospital, Shaoxing 312030, China.

ORCID-Profile: Chenxi Wu, Anqi Lyu

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Wu, C., Lyu, A., & Shan, S. (2023). Fulvic Acid Attenuates Atopic Dermatitis by Downregulating CCL17/22. Molecules. https://doi.org/10.3390/molecules28083507

Vancouver

Wu C, Lyu A, Shan S. Fulvic Acid Attenuates Atopic Dermatitis by Downregulating CCL17/22. Molecules. 2023. doi:10.3390/molecules28083507

BibTeX
@article{Wu2023,
  author = {Wu, Chenxi and Lyu, Anqi and Shan, Shijun},
  title = {Fulvic Acid Attenuates Atopic Dermatitis by Downregulating CCL17/22},
  journal = {Molecules},
  year = {2023},
  doi = {10.3390/molecules28083507}
}
Kostenlos starten →